Navigation Links
Haemacure Reports on its annual general and special meeting of shareholders
Date:4/9/2008

HAE:TSX

MONTREAL, April 9 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX : HAE), a Montreal-based specialty bio-therapeutics company developing high-value human plasma-derived protein products for commercialization, reports on its Annual General and Special Meeting of Shareholders held this afternoon.

Results of Preclinical Study of Fibrin Sealant in Adhesion Prevention

Haemacure presented the positive results of a preclinical study it recently conducted on the use of the current formulation of its proprietary lead product candidate, the human fibrin sealant Hemaseel(R)HMN. Haemacure's fibrin sealant proved superior to the untreated control subjects in open surgery in preventing the formation of post-surgical adhesions. It also proved to be superior to the data found in published literature for GYNECARE INTERCEED(TM) (TC7) Absorbable Adhesion Barrier, marketed by Ethicon, Inc. Haemacure plans on expanding the fields of use for its fibrin sealant by entering the adhesion prevention market, thanks to the leveraging of the current formulation of its fibrin sealant. Post-surgical adhesions are estimated to cost the U.S. healthcare system US$2.1 billion annually.

New Manufacturing Facility on Schedule and on Budget

Haemacure reported that the construction of its small scale manufacturing facility in Sarasota, Florida is progressing on schedule and on budget. The targeted completion date is mid-2008, as planned. The construction of a small-scale facility is the first phase of Haemacure's two-phase strategy to significantly reduce the cost of meeting its First-Patient-In objective during the first quarter of 2009. The second phase of the strategy consists in expanding the facility during the review of its license applications by regulatory authorities, and in completing the development of Haemacure's second product candidate, the Hemaseel(R)Thrombin active hemostatic agent. Haemacure's fibrin seal
'/>"/>

SOURCE Haemacure Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Haemacure Reports Third Quarter 2007 Results
2. Haemacure Adopts Strategy for "First-Patient-In" Fibrin Sealant Pivotal Clinical Trials
3. Haemacure announces webcast of presentation at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conferencec
4. Haemacure Announces Details of its Annual General and Special Meeting of Shareholders
5. Media Invitation - Annual General and Special Meeting of Shareholders of Haemacure
6. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
7. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
8. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
9. MDS Reports Third Quarter 2007 Results
10. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
11. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... 01, 2014 Marriagelifeinsurance.com has released ... insurance for retired couples. , Senior citizens can ... security for their loved ones. A joint policy is ... persons pass away. , Life insurance can be ... insurance can even be purchased online, as the application ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Lifeinsurance-policy.com ... find the best life insurance prices for smokers. , ... life insurance premiums. Comparing quotes is the best method ... finding quotes for customers who need coverage. , ... entire duration of the policy. Since the coverage is ...
(Date:10/1/2014)... D.C. and ATLANTA (PRWEB) October 01, 2014 ... information security executive networking and relationship-marketing firm, ... 2014 Information Security Executive® and Project of ... include top-ranking decision makers representing organizations in ... academics. Projects include large-scale technology endeavors that ...
(Date:10/1/2014)... genetic finding from Duke Medicine suggests that some people ... also be hard-wired to gain weight when exposed to ... An estimated 13 percent of people, all of whom ... this could help them reduce heart disease with simple ... management. , "Genetic susceptibility, psychosocial stress and metabolic factors ...
(Date:10/1/2014)... 2014 Innovations announces the upcoming airing ... on Monday, October 20, 2014 at 7:30 a.m. EST/PT ... go behind the scenes to learn about Break the ... explore the practical help and information Break the Cycle ... warning signs of abuse, how to navigate the legal ...
Breaking Medicine News(10 mins):Health News:Elderly Life Insurance - Find Life Insurance for Retired Couples! 2Health News:Affordable Whole Life Insurance Premiums for Smokers! 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 3Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 4Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 5Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 6Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 7Health News:Gene interacts with stress and leads to heart disease in some people 2Health News:Innovations to Explore Breakthroughs in Health and Wellness in Upcoming Episode Airing Monday, October 20, 2014 via Discovery Channel 2
... high efficiency particle air (HEPA) filters along with ... cardiovascular health, according to researchers in Denmark. In ... filters for just two days significantly improved a ... elderly individuals. , Reduction of particle exposure by ...
... Calif., Feb. 15 Concentric Medical,Inc., the global leader ... announced the addition of Kimberly Bridges to its,management team ... a $15 million,line of credit., "We are delighted ... President and CEO of Concentric Medical. "Concentric is,entering a ...
... who showed that a single prostate specific antigen (PSA) test ... prostate cancer up to 25 years later, (regardless of clinical ... used to predict advanced prostate cancer. , The findings, ... help physicians identify which men would benefit from intensive screening. ...
... RUTHERFORD, N.J., Feb. 14 Cambrex,Corporation (NYSE: CBM ) reports ... 2007., (Logo: http://www.newscom.com/cgi-bin/prnh/20000613/CAMBREXLOGO ), ... (-0.2% excluding foreign currency) compared to ... 6.7% (2.0% excluding foreign currency) compared to 2006. ...
... National Penn Bancshares Inc. (NASD:,NPBC) will replace Bradley Pharmaceuticals ... after the close of trading on Thursday, February 21, ... close on or about that date,pending final approvals., ... any relevant,updates on its website: http://www.standardandpoors.com ., ...
... The American people,through the U.S. Agency for ... program in Pakistan on child spacing and,reproductive health ... "FALAH is a visionary program that applies ... to deliver family planning services effectively and,explores new ...
Cached Medicine News:Health News:Using HEPA filters may improve cardiovascular health 2Health News:Early warning: PSA testing can predict advanced prostate cancer 2Health News:Cambrex Reports Fourth Quarter and Full-Year 2007 Results 2Health News:Cambrex Reports Fourth Quarter and Full-Year 2007 Results 3Health News:Cambrex Reports Fourth Quarter and Full-Year 2007 Results 4Health News:Cambrex Reports Fourth Quarter and Full-Year 2007 Results 5Health News:Cambrex Reports Fourth Quarter and Full-Year 2007 Results 6Health News:Cambrex Reports Fourth Quarter and Full-Year 2007 Results 7Health News:Cambrex Reports Fourth Quarter and Full-Year 2007 Results 8Health News:Cambrex Reports Fourth Quarter and Full-Year 2007 Results 9Health News:Cambrex Reports Fourth Quarter and Full-Year 2007 Results 10Health News:Cambrex Reports Fourth Quarter and Full-Year 2007 Results 11Health News:Cambrex Reports Fourth Quarter and Full-Year 2007 Results 12Health News:Cambrex Reports Fourth Quarter and Full-Year 2007 Results 13Health News:Cambrex Reports Fourth Quarter and Full-Year 2007 Results 14Health News:Standard & Poor's Announces Change to U.S. Index 2
(Date:9/30/2014)... Sept. 30, 2014  Alimera Sciences, Inc. (NASDAQ: ... in the research, development and commercialization of prescription ophthalmic ... million advance from Hercules Technology Growth Capital, Inc. (NYSE: ... second and final advance under the Loan and Security ... Kingdom , Alimera Sciences Limited, entered into with ...
(Date:9/30/2014)... 30, 2014 A study using a relatively ... new look at the composition of carotid artery disease ... and treat the disease, a leading cause of stroke. ... Lexington between September 2010 and May 2012, was featured ... of the American College of Cardiology (JACC) Cardiovascular Interventions. ...
(Date:9/30/2014)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... Bridgewater, New Jersey location received ... Administration (FDA) relating to an inspection in June 2014 ... injectable, which was divested to Galderma S.A. in July ... contract manufacturers (rather than Valeant,s own internal manufacturing) with ...
Breaking Medicine Technology:Alimera Sciences Receives $25 Million Advance from Hercules Technology Growth Capital 2New Imaging Tool May Allow Tailoring of Stroke Prevention to Each Patient 2Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA 2
... Hand Instruments were developed in surgeon's desire ... still having an instrument with the strength ... fear of the bending or breaking. Arthrotek ... to conform to the surgeon's hand. This ...
The narrow shaft and compact jaw design facilitates access and use in tight spaces, particularly useful in the posterior aspect of the knee....
... Hand Instruments were developed in surgeon's desire ... still having an instrument with the strength ... fear of the bending or breaking. Arthrotek ... to conform to the surgeon's hand. This ...
... Instruments were developed in surgeon's desire to ... having an instrument with the strength to ... of the bending or breaking. Arthrotek Hand ... conform to the surgeon's hand. This new ...
Medicine Products: